Dr. Magid is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4131 Spicewood Springs Suite G-5
Austin, TX 78759Phone+1 512-985-9301Fax+1 512-985-9281
Summary
- Dr. Michelle Magid is a psychiatrist in Austin, TX and is affiliated with multiple hospitals in the area, including Ascension Seton Medical Center Austin and Dell Seton Medical Center at the University of Texas. She received her medical degree from Boston University School of Medicine and has been in practice 20 years. She specializes in neuropsychiatry and psychopharmacology. With over 100 publications and lectures, she is considered a national expert in mood and axiety related disorders.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Psychiatry, 2002 - 2006
- Boston University School of MedicineClass of 2002
- University of Texas, Naveen Jindal School of Management MBA, Business
Certifications & Licensure
- TX State Medical License 2006 - 2025
- MN State Medical License 2003 - 2007
- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- Young investigators Award Brain and Behavior Institute
- Distinguished Fellow American Psychiatric Association, 2023
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 16 citationsPsychocutaneous disease : Pharmacotherapy and psychotherapyHelena Kuhn, Constance Mennella, Michelle Magid, Caroline Stamu-O'Brien, George Kroumpouzos
Journal of the American Academy of Dermatology. 2017-05-01 - 76 citationsTreatment of Major Depressive Disorder Using Botulinum Toxin A: A 24-Week Randomized, Double-Blind, Placebo-Controlled StudyMichelle Magid, Jason S. Reichenberg, Poppy E. Poth, Henry T. Robertson, Amanda K. LaViolette
The Journal of Clinical Psychiatry. 2014-05-13 - 18 citationsBotulinum toxin for the management of depression: An updated review of the evidence and meta-analysis.Jara Schulze, Insa Neumann, Michelle Magid, Eric Finzi, Christopher Sinke
Journal of Psychiatric Research. 2021-01-21
Press Mentions
- Schneider Shorts 2.07.2021- Rethink Evolution!July 2nd, 2021
- Reviewers' List December 2017October 3rd, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: